Bay Street News, June 13th, 2024

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed […]

BETHESDA, Md., June 13, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced the pricing […]

NOVATO, Calif., June 13, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]

KIRKLAND, Wash., June 13, 2024 (GLOBE NEWSWIRE) — Monolithic Power Systems, Inc. (Nasdaq: MPWR), a global company that provides high-performance, […]

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced that Arm Holdings plc (Nasdaq: ARM), will […]

Fully underwritten Retail Entitlement Offer to raise a further approximately A$55.9m (US$36.9m1) will open on 19 June 2024 and close […]

GREENWICH, Conn., June 13, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by QXO, […]

SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (“Vaxart”) (Nasdaq: VXRT) today announced an underwritten offering […]

GREENWICH, Conn., June 13, 2024 (GLOBE NEWSWIRE) — QXO, Inc. (Nasdaq: QXO) (the “Company” or “QXO”), a company expected to […]

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (Nasdaq: VIRT) (“Virtu”) announced today that its subsidiaries, VFH […]